In inflammatory bowel diseases (IBD), certain chromosomal candidate loci have been repeatedly identified by independent studies in different populations. To investigate the contribution of the loci on chromosomes 1, 3, 7, 12, 14, and 16 to the susceptibility of IBD in Finnish population, where the predominant feature is the excess of ulcerative colitis (UC) families compared to Crohn's disease (CD) families, we carried out linkage analyses using 93 Finnish, multiply-affected IBD families. We observed nominal evidence for linkage to chromosome 3p21, consistent with earlier reports. The lod scores peaked at D3S2432, with a maximum two-point lod score of 1.68 (P=0.0027). In addition, we studied whether risk of IBD is associated with functional variants of two positional candidate genes; the chemokine receptor CCR5 gene on chromosome 3p21 and the interleukin-4 receptor a-subunit gene (IL4RA) on chromosome 16. We did not find any significant correlation between a 32-bp deletion variant of CCR5 or a single nucleotide change A1902G (Gln576Arg) of IL4RA, and IBD phenotypes, with the exception that in the UC group homozygosity for the G1902 allele of IL4RA was less frequent (0.019 vs 0.049, P=0.038). In conclusion, our study, carried out in a genetically homogenous population, suggests that chromosome 3 may contain a susceptibility gene for IBD.
Introduction
Studies of the genetic susceptibility to inflammatory bowel disease (IBD) have resulted in the discovery of several chromosomal areas of interest during recent years. The most encouraging results concern Crohn's disease (CD) which is linked in most studied populations to chromosome 16 pericentromeric region (IBD1 locus), 1 ± 10 and in two independent studies to chromosome 14. 11, 12 Evidence for a relatively strong genetic basis of CD has also earlier been obtained by epidemiological data. For instance, the reported concordance rate of the disease between monozygotic twins is greater for CD (20 ± 44%) than ulcerative colitis (UC, 6 ± 16%). 13 Linkage to another promising IBD locus (IBD2) on chromosome 12 has been supported by many independent studies, especially in UC families. 2, 7, 10, 11, 14 The locus on chromosome 6p referred to as IBD3 locus is not as definitively replicated as the IBD1 and IBD2 loci. 15 ± 17 Linkage to chromosome 1 in American
Chaldean population is the only linkage report, so far, from an isolated population, 18 that strengthens and restricts the assignment of the susceptibility locus previously reported in outbred population.
The Finnish population represents a genetic isolate and may provide advantages in genetic studies on complex diseases. Based on epidemiological data from the southcentral part of the country, the prevalence of UC has been estimated as 121/100 000 and that of CD as 44/100 000 among the Finns. 19 As the first part of a systematic search for IBD susceptibility genes in the Finnish population, we conducted a linkage study on the most attractive candidate loci on chromosomes 1, 3, 7, 12, 14 and 16 in 93 IBD families.
In addition, functional alterations in two positional candidate genes, 20 ± 22 one encoding the chemokine receptor CCR5
on chromosome 3p21 and the other encoding the interleukin-4 receptor alpha subunit (IL4RA) on chromosome 16, were analysed in a separate case-control study of unrelated individuals.
Materials and methods

Family ascertainment and sample collection
We recruited IBD patients from all over Finland using strict diagnostic criteria based on typical clinical characteristics as well as diagnostic findings on both visual inspection by successful ileocolonoscopy and histopathological examination of biopsy specimens. The clinical diagnosis of each patient was confirmed by at least two members of the research group. Individual families consisting of at least two siblings with a diagnosis of either CD, UC or indeterminate colitis, were identified and collected. Families with a history of IBD in the relatives of both parents of the sib-pairs were excluded. Eventually 93 IBD families, containing a total of 124 sib-pairs, were accepted into the linkage study (Table 1) . Both parents were available for analysis in 38% of the 93 families. The definition for a mixed family denotes sibships with both UC and CD; only in five families one of the siblings had indeterminate colitis. In the association study, we genotyped 155 familial (with a known 1st degree affected relative) IBD patients, 280 sporadic IBD patients, and 183 healthy controls for the common CCR5 and IL4RA polymorphisms. The controls were healthy voluntary blood donors (91 men, 92 women) aged 40 to 50 years (mean 45 years) collected from the Finnish Red Cross Blood Service, and had their residencies in the capital region of Finland where approximately 70% of the patients were living. In addition, we genotyped the whole family cohort (Table 1) for the IL4RA polymorphism. Informed written consent was obtained from all study participants, and the study protocol was accepted by the Ethical Review Committee of Helsinki University Central Hospital.
Genetic analysis
All the blood samples for DNA isolation were collected in accordance with the Helsinki declaration. Microsatellite markers spanning the IBD candidate regions originated from the marker collections of Ge Âne Âthon and the Cooperative Human Linkage Center (CHLC) (http://lpg.nci.nih.gov/ CHLC/). Genotyping was performed using 96-well format both in PCR with fluorescently labelled primers and in electrophoresis of the pooled amplified products. Data collection was based on the use of an ABI377 automated DNA sequencer (Perkin Elmer, Applied Biosystems), and data analyses were performed with the Genescan 2.0 and Genotyper software programs. The genotype data were processed using LINKBASE, the Windows-based database system designed to connect the genotype data produced by automatic sequencers to linkage analysis programs (http:// www.ktl.fi/molbio/software/linkbase).
Analyses of candidate gene polymorphisms
Genotyping of the CCR5 insertion/deletion polymorphism was performed by amplifying DNA by PCR using primers 5'-T G T T T G C G T C T C T C C C A G -3 ' a n d 5 ' -C A -CAGCCCTGTGCCTCTT-3' resulting in a 232 bp product for the wild type allele and a 200 bp product for the mutant allele (D32) upon agarose gel electrophoresis. The A1902G polymorphism of the IL4RA gene was genotyped according to the protocol described by Noguchi et al.
23
Statistical analysis
In order to take advantage of the extended nature of the family cohort, two-point pairwise linkage analyses using affecteds-only dominant and recessive pseudomarker analysis were performed, 24 using the MLINK program of the LINKAGE package, 25 FASTLINK version 2.2. 26 This method is analogous to comparison of the proportion of alleles affected relatives share identical by descent in families of general structure. 24 A two-point analysis was preferred to multipoint analysis because the latter is more sensitive to misspecification of intermarker distances and allele frequencies. 24 P values 50.05 are presented in the tables, to allow the comparison of lod scores and non-parametric lod (NPL) scores that were used in most of the previous IBD reports. We also present for each marker the NPL scores calculated by using the Genehunter 2.0 beta software. 27 Multipoint NPL analyses for each chromosome were also performed but they 
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Power analyses were performed to estimate the probability of detecting linkage under various gene effect sizes, eg, proportion of linked families (a), using the SIMSIBS program which was also used for the simulation analyses in the articles by Terwilliger et al. and Go Èring et al. 24, 29 The extended nature of our family cohort was not taken into account, but the estimates were based on the total amount of sib-pairs of our family cohort. On the other hand, these power calculations assume that genotypes were known for all individuals. We assumed the average marker heterozygosity to be 80% and recombination fraction of 0.05 between marker and disease loci. Based on the calculations, under this sample size (only sibships included) our family cohort could permit detection of major loci (a40.40) contributing to susceptibility to IBD (data not shown). The statistical analysis for association in the candidate gene study was performed by using Pearson chi-square statistics with the BMDP software (BMDP Statistical Software Inc., Los Angeles, CA, USA).
Results
Linkage analyses of candidate chromosomal loci
The family cohort consisted of 53 UC families, 16 CD families, and 24 mixed families, containing 229 affected individuals (114 male and 115 female) and 145 non-affected individuals. The majority of the patients (68.4%) had diagnosis of UC (n=156). Five patients had the diagnosis of indeterminate colitis and 68 patients the diagnosis of CD. The age of the patients ranged from 12 to 86 years (mean and median, 47 years). The mean age of disease onset (age at diagnosis) was slightly lower in CD families (mean 28.4 years, median 27.5 years) compared to UC families (mean 33 years, median 30 years) or mixed families (mean 33 years, median 32.5 years). Nominal evidence for linkage was observed on chromosome 3p21. The lod scores peaked at D3S2432 where the maximum two-point lod score obtained by the recessive pseudomarker analysis was 1.68 (P=0.0027, y=0.26) and the NPL score 1.89 (P=0.029) ( Table 2 ). In the multipoint NPL analysis the maximum lod score was 1.71 (P=0.043) near D3S2432. As the family composition did not represent a pure sib-pair material, the lod score in affected sib-pair analysis (ASP) for the total study sample (lod score=1.48; P=0.0045) was slightly less significant. The marker D3S1619, approximately 3 cM telomeric to D3S2432, gave a maximum lod score of 0.98 (P=0.017) in the recessive pseudomarker linkage analysis. Stronger evidence for linkage was obtained in the mixed group where the lod score was 1.47 (P=0.0047, Table  3 ). In the UC group at D3S1619, the haplotype relative risk test gave a P-value of 0.019 (0.057 for the total family cohort and 0.03 for the UC-mixed group), which reflects a minor overrepresentation of the allele 9 in the affected chromosomes (23%) compared to control chromosomes (10%).
The analyses carried out for subgroups defined by disease onset (age 530 or 522 years) or parents' birth places (Southwestern vs Northeastern Finland) did not give any more significance to the linkage analysis (data not shown). Multipoint non-parametric analyses did not add information content on the families that we studied: for 3p21 the highest two-point NPL score was 1.89 whereas the highest multipoint NPL score was 1.71 near D3S2432. In the disease-specific analyses, CD families did not seem to contribute to the linkage evidence (Table 3) , which was also evident in the multipoint NPL analyses on 3p21 (Figure 1) . On chromosome 16, in the affecteds-only analysis the marker D16S407 gave a maximum two-point lod score of 0.93 (P=0.019) and a NPL score of 1.63 (P=0.049) for the CD group consisting of 16 families with two affected sibs ( Table 2 ). Here also, the multipoint NPL analysis did not give any more significance to the results (data not shown). In other groups, and in the total study group, the lod scores for chromosome 16 markers remained non-significant. The non-significant results for other loci on chromosomes 1, 7, 12 and 14 are presented in Table 2 .
Association analyses of the functional variants of CCR5 and IL4RA
The genotype or allele frequencies of the CCR5 insertion/ deletion polymorphism did not differ significantly between the unrelated inflammatory bowel disease (IBD) patients and controls (Table 4) . Furthermore, no significant differences in these frequencies emerged, when calculations were carried out in different disease types, or when sporadic IBD was compared to familial IBD. The IL4RA allele (A1902G) frequencies were similar in the IBD group and the control group, but the genotype frequencies showed minor differences in these two groups (Table 4) . There was no significant deviation of the observed genotype frequencies from the Hardy-Weinberg's equilibrium in the patient or control groups (P40.10). In the IBD group, the homozygous genotype for the variant allele 1902G was less frequent (0.019 vs 0.049, P=0.038) and the heterozygous genotype more frequent (0.36 vs 0.28) than the corresponding frequencies in the controls. No excess transmission of either of the IL4RA alleles to affected individuals was observed in the HRR-test of the whole family cohort (P=0.33).
Discussion
The present study supports the assumption that one of the genes conferring increased risk of IBD is located on Replication of linkage to 3p21 in Finnish IBD families P Paavola et al 330 chromosome 3p21. Our supportive linkage assignment overlaps the original linkage region on 3p21 reported by Satsangi et al. 2 So far, only the genome scan by Rioux et al. has shown multipoint lod scores over 1.5 on this region. 17 Satsangi et al.
observed the strongest evidence of linkage in CD families, 2 while in our material the greatest evidence of linkage seems to be from the mixed families, which may reflect greater average size of the families in this group. The chromosome 3 region has also raised attention in an association study by Pokorny et al. 30 who reported an increase of a specific haplotype, constructed from the alleles of the marker D3S1611 and the HNPCC (hereditary non-polyposis colon cancer) gene MLH1, in IBD patients. The chromosome 3p21 region seems intriguing as it harbours, in addition to MLH1, other interesting candidates genes including those encoding a cluster of chemokine receptors, and a G protein subunit a i2 (GNAI2) the deficiency of which causes an UC-like phenotype in knockout mice. 31 A striking feature of the composition of our family material was the relative excess of UC families to CD families. The threefold difference in prevalence rates of UC to CD, similar to the situation observed elsewhere, can not wholly explain this. Whether this means that different combinations of susceptibility genes for IBD exist in the Finns in comparison to other populations remains to be studied. Due to the nature of complex genetics and our restricted sample size regarding especially the CD families, failure to replicate previous findings on other chromosomes than 3p21, however, does not exclude the possibility that these regions would harbour Finnish IBD genes. We take our findings on the pericentromeric markers of chromosome 16 as preliminarily interesting as positive lod scores with 16 CD families for the marker D16S407 were observed.
We selected two candidate genes showing common functional variation, one in chromosome 3 (chemokine receptor CCR5) and the other in chromosome 16 (IL4RA), Note. Maximum two-point lod scores (Z max ) obtained by using the pseudomarker analysis with recessive (Rec) or dominant model (Dom) and by affected sib-pair analysis (ASP). Two-point NPL scores are also shown. P values 50.05 are indicated in parentheses. The genetic distances (cM; centiMorgan) are based on human GeneMap (http://www.ncbi.nlm.nih.gov/genemap), except the distances for chromosome 1, which are derived from the comprehensive Marshfield genetic map. Only the significant results obtained in the subgroup analysis for disease type are presented. For the disease-specific analyses of chromosome 3 markers see Table 3 .
for a genetic association study. CCR5 has been shown to be abundantly expressed in colon epithelial cell lines and regulate proinflammatory chemokine production. 32 A naturally occurring variant of CCR5 exists, where a 32-bp deletion results in synthesis of a non-functional receptor due to generation of a premature stop codon. This D32 variant was first identified in individuals resistant to HIV-1 infection, and was subsequently associated with reduced risk of asthma, 22 possibly pointing to less liability to chronic inflammation. We did not find any significant, positive or negative, association between risk of IBD and the D32 variant of CCR5, and there was no specific IBD group with an apparent loss of the D32/D32 homozygotes (Table 4) . A nucleotide change A1902G of IL-4 receptor a-subunit, causing the replacement of glutamine (Q576) with arginine (R576), has been reported to result in increased IL-4 signaling and increased IgE production in vivo, and was initially suggested to be associated with atopy. 21 Interestingly, a defect in responsiveness to IL-4 has been proposed in IBD. 20 Accordingly, we hypothesised that the G1902 allele of IL4RA could be less prevalent in IBD patients than in normal controls. Although the G1902 allele frequencies were similar in the IBD group and the controls, the homozygous G1902/ G1902 genotype was slightly less common in UC patients than in controls (Table 4) . Whether this is an indication that the IL4RA G1902 allele, when present in a homozygous form, Figure 1 Multipoint non-parametric linkage analysis on chromosome 3p21 for the total family cohort (IBD) and diseasespecific subgroups (UC, CD, and mixed families). Multipoint lod scores (MLS) were calculated by using Genehunter 2.0 version beta.
Replication of linkage to 3p21 in Finnish IBD families P Paavola et al 332 may exert a weak protective influence against risk of UC in specific individuals awaits additional studies using other data sets. A recent study by Olavesen et al. did not, however, reveal any significant association between risk of IBD and several intragenic single-nucleotide polymorphisms of the IL4RA gene. 33 In conclusion, our study carried out in the relatively isolated Finnish population further strengthens the linkage to 3p21 reported in more outbred populations and thus supports the assumption that chromosome 3 contains a gene or genes conferring susceptibility to IBD. 
European Journal of Human Genetics
Replication of linkage to 3p21 in Finnish IBD families P Paavola et al 333
